NL7308267A - - Google Patents

Info

Publication number
NL7308267A
NL7308267A NL7308267A NL7308267A NL7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A
Authority
NL
Netherlands
Application number
NL7308267A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7308267A publication Critical patent/NL7308267A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL7308267A 1972-06-15 1973-06-14 NL7308267A (enrdf_load_stackoverflow)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (1)

Publication Number Publication Date
NL7308267A true NL7308267A (enrdf_load_stackoverflow) 1973-12-18

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7308267A NL7308267A (enrdf_load_stackoverflow) 1972-06-15 1973-06-14

Country Status (9)

Country Link
BE (1) BE800899R (enrdf_load_stackoverflow)
CA (1) CA1040619A (enrdf_load_stackoverflow)
DE (1) DE2330342A1 (enrdf_load_stackoverflow)
DK (1) DK136157B (enrdf_load_stackoverflow)
FR (1) FR2189034B2 (enrdf_load_stackoverflow)
GB (1) GB1434919A (enrdf_load_stackoverflow)
LU (1) LU67790A1 (enrdf_load_stackoverflow)
NL (1) NL7308267A (enrdf_load_stackoverflow)
ZA (1) ZA734037B (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
SG10201802389SA (en) 2013-04-17 2018-04-27 Sage Therapeutics Inc 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
HUE051403T2 (hu) 2013-04-17 2021-03-01 Sage Therapeutics Inc Neuroaktív 19-nor-szteroidok kezelési eljárásokhoz
AU2014290400B2 (en) 2013-07-19 2019-12-05 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
PT3035940T (pt) 2013-08-23 2019-01-28 Sage Therapeutics Inc Esteroides neuroativos, composições e seus usos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
SI3206493T1 (sl) 2014-10-16 2020-10-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
WO2016061527A1 (en) 2014-10-16 2016-04-21 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
DK3224269T3 (da) 2014-11-27 2020-05-25 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
RS61530B1 (sr) 2015-01-26 2021-04-29 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2017297375B2 (en) 2016-07-11 2022-09-15 Sage Therapeutics, Inc. C17, C20, and C21 substituted neuroactive steroids and their methods of use
NZ790187A (en) 2016-07-11 2025-08-29 Sage Therapeutics Inc C7, C12, and C16 substituted neuroactive steroids and their methods of use
KR20220016098A (ko) 2019-05-31 2022-02-08 세이지 테라퓨틱스, 인크. 신경활성 스테로이드 및 이의 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (de) * 1942-04-25 1951-02-28 Nv Organon Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe.
DK133682B (da) * 1970-12-17 1976-06-28 Glaxo Lab Ltd Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-5alfa-pregn-1-en-20-oner eller 3alfa-hydroxy-17beta-alkoxykarbonyl-5alfa-androst-1-ener.
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof

Also Published As

Publication number Publication date
FR2189034B2 (enrdf_load_stackoverflow) 1977-01-21
CA1040619A (en) 1978-10-17
DK136157C (enrdf_load_stackoverflow) 1978-01-23
DK136157B (da) 1977-08-22
BE800899R (fr) 1973-12-14
DE2330342A1 (de) 1974-01-17
LU67790A1 (enrdf_load_stackoverflow) 1973-08-16
ZA734037B (en) 1974-05-29
GB1434919A (en) 1976-05-12
FR2189034A2 (enrdf_load_stackoverflow) 1974-01-25
AU5693773A (en) 1974-12-19

Similar Documents

Publication Publication Date Title
JPS4956060A (enrdf_load_stackoverflow)
JPS4887683A (enrdf_load_stackoverflow)
JPS4899258A (enrdf_load_stackoverflow)
DK136157C (enrdf_load_stackoverflow)
FR2208240B1 (enrdf_load_stackoverflow)
JPS4931615U (enrdf_load_stackoverflow)
JPS5138587Y2 (enrdf_load_stackoverflow)
JPS4919269A (enrdf_load_stackoverflow)
JPS4941974U (enrdf_load_stackoverflow)
JPS4979663A (enrdf_load_stackoverflow)
CH583160A5 (enrdf_load_stackoverflow)
BG19824A1 (enrdf_load_stackoverflow)
CH568007A5 (enrdf_load_stackoverflow)
CH567666A5 (enrdf_load_stackoverflow)
CH572557A5 (enrdf_load_stackoverflow)
CH563142A5 (enrdf_load_stackoverflow)
CH563047A5 (enrdf_load_stackoverflow)
CH559877A5 (enrdf_load_stackoverflow)
CH586418B5 (enrdf_load_stackoverflow)
CH585821A5 (enrdf_load_stackoverflow)
CH573038A5 (enrdf_load_stackoverflow)
CH582294A5 (enrdf_load_stackoverflow)
CH582124A5 (enrdf_load_stackoverflow)
CH581671A5 (enrdf_load_stackoverflow)
CH581156A5 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
BV The patent application has lapsed